Azmitia E.C., Segal M. (1978) An autoradiographic analysis of the differential ascending projections of the dorsal and median raphe nuclei in the rat. J Comp Neurol179: 641-668
2.
Beitz A.J., Clements J.R., Mullett M.A., Ecklund L.J. (1986) Differential origin of brainstem serotonergic projections to the midbrain periaqueductal gray and superior colliculus of the rat. J Comp Neurol250: 498-509
3.
Blier P., de Montigny C. (1990) Electrophysiological investigation of the adaptive response of the 5-HT system to the administration of 5-HT1A receptor agonists. J Cardiovasc Pharmacol (Suppl 17): S42-48
4.
Carli M., Samanin R. (1988) Potential anxiolytic properties of 8-hydroxy-2-(di-n-propylamino)tetralin, a selective serotonin 1A receptor agonist. Psychopharmacology94: 84-91
5.
Cloninger C.R. (1987) Recent advances in the genetics of anxiety and somatoform disorders. In Meltzer H Y (ed.), Psychopharmacology: the third generation of progress. Raven Press, New York, pp. 955-965
6.
Critchley M A E, Handley S.L. (1987) Effects in the X-maze anxiety model of agents acting at 5-HT1 and 5-HT2 receptors. Psychopharmacology93: 502-506
7.
Critchley M A E, Njung'e K., Handley S.L. (1991) Actions and some interactions of 5-HT1A ligands in the elevated X-maze and effects of dorsal raphe lesions. Psychopharmacology (in press)
8.
Deakin J F W (1983) Roles of serotonergic systems in escape, avoidance and other behaviours. In Cooper S J (ed), Theory in Psychopharmacol2: 149-193
9.
Deakin J F W (1988) 5-HT2 receptors, depression and anxiety . Pharmacol Biochem Behav29: 819-820
10.
Dourish C., Hutson P., Curzon G. (1986) Putative anxiolytics 8-OH-DPAT, buspirone and TVX Q 7821 are agonists at 5-HT1A autoreceptors in the raphe nuclei . Trends Pharmacol Sci7: 212-214
11.
File S.E. (1990) One-trial tolerance to the anxiolytic effects of chlordiazepoxide in the plus-maze. Psychopharmacology100: 281-282
12.
Graeff F.G. (1988) Animal models of aversion. In Simon P, Soubrié P, Wildlocher D (eds), Animal models of psychiatric disorders 1. Karger, Basel, pp. 115-141
13.
Gray J.A. (1982) The neuropsychology of anxiety: an enquiry into the functions of the septo-hippocampal system. Oxford University Press, Oxford, pp. 3-14
14.
Handley S.L. (1991) Serotonin in animal models of anxiety: the importance of stimulus and response. In Idzikowski C , Cowen P J (eds), Serotonin, sleep and mental disorder. Wrightson Biomedical , Petersfield, pp. 89-115
15.
Handley S.L., Mithani S. (1984) Effects of alpha-adrenoceptor agonists and antagonists in a maze-exploration model of 'fear'-motivated behaviour. Naunyn-Schmiedeberg's Arch Pharmacol327: 1-5
16.
Hodges H., Green S., Glenn B. (1987) Evidence that the amygdala is involved in benzodiazepine and serotonergic effects on punished responding but not in discrimination . Psychopharmacology92: 491-504
17.
Invernizzi R.W., Cervo L., Samanin R. (1988) 8-Hydroxy-2-(din-propylamino)tetralin, a selective serotonin 1A receptor agonist, blocks haloperidol-induced catelepsy by an action on raphe nuclei medianus and dorsalis. Neuropharmacology27: 515-518
18.
Klein D.F., Klein H.M. (1989) The definition and psychopharmacology of spontaneous panic and phobia. In Tyrer P (ed.), The psychopharmacology of anxiety. Oxford University Press , Oxford, pp. 135-162
19.
Lee M.A., Nash J.F., Barnes M., Meltzer H.Y. (1991) Inhibitory effect of ritanserin on the 5-hydroxytryptophan-mediated cortisol, ACTH and prolactin secretion in humans. Psychopharmacology103: 258-264
20.
Lesch K.P., Mayer S., Disselkamp-Tietze J., Hoh A., Schoellnhammer G., Schulte H.M. (1990) Subsensitivity of the 5-hydroxytryptamine 1A (5-HT1A) receptor-mediated hypothermic response to ipsapirone in unipolar depression. Life Sci46: 1271-1277
21.
Montgomery K.C. (1955) The relation between fear induced by novel stimulation and exploratory behaviour. J Comp Physiol Psychol48: 254-260
22.
Montgomery S.A. (1989) New antidepressants and 5-HT uptake inhibitors . Acta Psychiatr Scand80 (suppl 350): 107-116
23.
Pellow S., Chopin P., File S.E. and Briley M. (1985) Validation of open: enclosed arm entries in an elevated plus-maze as a measure of anxiety in the rat. J Neurosci Meth14:149-167
24.
Soubrié P. (1988) Serotonin and behaviour, with special regard to animal models of anxiety, depression and waiting ability. In Osborne N N, Hamon M (eds) Neuronal serotonin. Wiley, New York, pp. 255-270
25.
Starkman M.N., Schteingart D.E. (1981) Neuropsychiatric manifestations of patients with Cushing's syndrome. Arch Intern Med141: 215-219
26.
Thiébot M.H., Jobert A., Soubrié P. (1980) Conditioned suppression of behaviour: its reversal by intra-raphe microinjection of chlordiazepoxide and GABA. Neurosci Lett16: 213-217
27.
Toates F. (1990) Obsessional thoughts and behaviour. Thorsons, Wellingborough.
